News & Events
ChemGenex Presents Updated Analysis at ASH on OMAPROâ?˘in CML Patients who Failed Two or Three Approved TKI Drugs
06 / 12 / 2010
â?˘ New analysis of clinical data indicates that OMAPROTM could offer a new treatment approach for CML Patients who fail to respond to TKI therapy â?˘ OMAPROTM induced durable major cytogenetic responses in 33% of chronic phase patients who failed currently approved drugs
Sunshine Heart successfully completes $9.5 million capital raising with close of non-renounceable rights offer
03 / 12 / 2010
Euthymics Bioscience, Inc. Appoints Biotech Industry Veteran Walter Piskorski as Vice President, Technical Operations
18 / 11 / 2010
Company Moves into Permanent Headquarters in Cambridge
EUTHYMICS BIOSCIENCE, INC. NAMES BIOTECH EXECUTIVE TIMOTHY J. BARBERICH TO BOARD OF DIRECTORS
04 / 11 / 2010
Former Sepracor Founder and CEO Brings a History of Experience and Success in Drug Development and Commercialization
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
01 / 11 / 2010
ChemGenex Announces Convertible Note Issue and Welcomes Cephalon, Inc. as a Substantial Investor
22 / 10 / 2010
â?˘ Substantial Shareholders Sign Option Agreements with Subsidiary of Cephalon, Inc over 19.9% of ChemGenex Shares at A$0.70 per Share
ChemGenex Completes pre-NDA Meeting with U.S. FDA and Clarifies Timing for Second New Drug Application for OMAPROTM
06 / 10 / 2010
CoDa Therapeuticsâ?? NEXAGON® Wound Healing Gel Named to Windhoverâ??s â??Top 10 HOT SPACE Projects to Watchâ?ť
17 / 09 / 2010
Sunshine Heart Announces First Minimally Invasive Thoracotomy Procedures Performed for the C-Pulse® Heart Assist System
31 / 08 / 2010
AIMEDICS secures funding for the commercialisation of its overnight hypoglycaemia monitor
27 / 08 / 2010
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader
17 / 08 / 2010
ChemGenex and U.S. FDA Agree on Potential Regulatory Pathway for OMAPRO:
13 / 07 / 2010
â?˘ Company will submit new NDA in CML patients who have failed multiple TKIs â?˘ Investor Teleconference to be held today - Wednesday 14th July 10.30am AEST /Tuesday 13th July 5.30
Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences
13 / 07 / 2010
Womenâ??s Sexual Health Research on Podium at 2010 Joint ICS/IUGA Meeting